Markus Linder

658 total citations
10 papers, 309 citations indexed

About

Markus Linder is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Markus Linder has authored 10 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Immunology. Recurrent topics in Markus Linder's work include Cytokine Signaling Pathways and Interactions (2 papers), RNA Research and Splicing (2 papers) and Click Chemistry and Applications (1 paper). Markus Linder is often cited by papers focused on Cytokine Signaling Pathways and Interactions (2 papers), RNA Research and Splicing (2 papers) and Click Chemistry and Applications (1 paper). Markus Linder collaborates with scholars based in Austria, Switzerland and Spain. Markus Linder's co-authors include Maria Sibilia, Erwin F. Wagner, Latifa Bakiri, Martin Holcmann, Kazuhiko Matsuoka, Christine Hartmann, Elisabeth Glitzner, Fernando Lecanda, Amanda Mikels‐Vigdal and Ana Patiño‐García and has published in prestigious journals such as Oncogene, PLoS Biology and Cell Death and Differentiation.

In The Last Decade

Markus Linder

10 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Linder Austria 7 190 76 73 61 44 10 309
Benjamin T. Dake United States 6 218 1.1× 69 0.9× 71 1.0× 53 0.9× 48 1.1× 7 355
Hidetaka Ohnuki United States 10 204 1.1× 75 1.0× 83 1.1× 47 0.8× 33 0.8× 23 385
Yelitza A. R. Rodriguez United States 7 153 0.8× 66 0.9× 64 0.9× 63 1.0× 42 1.0× 8 320
Jianchao Zheng China 11 211 1.1× 87 1.1× 45 0.6× 58 1.0× 44 1.0× 24 331
Emilie Evanno France 6 208 1.1× 62 0.8× 52 0.7× 72 1.2× 28 0.6× 7 334
Kyle M. LaPak United States 6 187 1.0× 113 1.5× 55 0.8× 55 0.9× 63 1.4× 11 353
Xiaobin Yu China 12 164 0.9× 87 1.1× 60 0.8× 65 1.1× 33 0.8× 19 327
Sampa Ghose India 12 185 1.0× 67 0.9× 42 0.6× 99 1.6× 52 1.2× 20 344
Muhamad Ashraf Rostam Australia 8 263 1.4× 60 0.8× 72 1.0× 45 0.7× 29 0.7× 16 418
Dimitris C. Kanellis Denmark 10 209 1.1× 85 1.1× 62 0.8× 88 1.4× 31 0.7× 14 323

Countries citing papers authored by Markus Linder

Since Specialization
Citations

This map shows the geographic impact of Markus Linder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Linder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Linder more than expected).

Fields of papers citing papers by Markus Linder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Linder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Linder. The network helps show where Markus Linder may publish in the future.

Co-authorship network of co-authors of Markus Linder

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Linder. A scholar is included among the top collaborators of Markus Linder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Linder. Markus Linder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Linder, Markus, et al.. (2024). In vivo monitoring of active subretinal fibrosis in mice using collagen hybridizing peptides. Lab Animal. 53(8). 196–204. 2 indexed citations
3.
Gyoergy, Attila, Maria Akhmanova, Markus Linder, et al.. (2022). Fos regulates macrophage infiltration against surrounding tissue resistance by a cortical actin-based mechanism in Drosophila. PLoS Biology. 20(1). e3001494–e3001494. 18 indexed citations
4.
Linder, Markus, Richard Foxton, Sabine Uhles, et al.. (2021). Simultaneous Ang-2/VEGF-A inhibition prevents subretinal fibrosis progression in preclinical mouse models of choroidal neovascularization (CNV). Investigative Ophthalmology & Visual Science. 62(8). 349–349. 2 indexed citations
5.
Holcmann, Martin, Izabela Borek, Markus Linder, et al.. (2021). Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells. EMBO Molecular Medicine. 13(4). e12409–e12409. 59 indexed citations
6.
Matsuoka, Kazuhiko, Latifa Bakiri, Markus Linder, et al.. (2020). Wnt signaling and Loxl2 promote aggressive osteosarcoma. Cell Research. 30(10). 885–901. 80 indexed citations
7.
Linder, Markus, Manfred Hecking, Elisabeth Glitzner, et al.. (2018). EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation. Cell Death and Differentiation. 25(6). 1094–1106. 70 indexed citations
8.
Linder, Markus, Elisabeth Glitzner, Latifa Bakiri, et al.. (2018). EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling. EMBO Molecular Medicine. 10(11). 23 indexed citations
9.
Kauer, Maximilian, Raphaela Schwentner, Eleni M. Tomazou, et al.. (2017). EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma. Oncogene. 36(43). 5995–6005. 41 indexed citations
10.
Linder, Markus, et al.. (1999). Inhibition of succinyl CoA synthetase histidine-phosphorylation in Trypanosoma brucei by an inhibitor of bacterial two-component systems. Molecular and Biochemical Parasitology. 100(1). 53–59. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026